About Oncosyne
Oncosyne is a company based in Oslo (Norway) founded in 2020. It operates as a B2B. Oncosyne offers products and services including iCAN R&D, iCAN IVD, and iCAN Tumoroid Platform. Oncosyne operates in a competitive market with competitors including Redbud Medicine, OncoTheis, AlphaVax, Lukas Biomedical and DXOCRO, among others.
- Headquarter Oslo, Norway
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Fortress Fund
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oncosyne
Oncosyne offers a comprehensive portfolio of products and services, including iCAN R&D, iCAN IVD, and iCAN Tumoroid Platform.
Supports pharmaceutical phases from discovery to clinical studies.
Personalizes cancer treatments using patient-derived tumoroids.
Tests drug efficacy and mechanisms for cancer candidates.
Funding Insights of Oncosyne
Investors in Oncosyne
Oncosyne has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Fortress Fund and StartupLab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Oncosyne
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oncosyne
Investment portfolio details for Oncosyne
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oncosyne
Detailed financials for Oncosyne
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oncosyne Comparisons
Peer comparison for Oncosyne
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oncosyne
Oncosyne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Redbud Medicine, OncoTheis, AlphaVax, Lukas Biomedical and DXOCRO, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Offers comprehensive services in regulatory affairs, R&D, data management, and statistical analysis for healthcare.
|
|
| Locked | Locked | Locked |
Provides 3D tissue testing services for in-vitro lung cancer drug testing.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases and cancer immunotherapy are developed.
|
|
| Locked | Locked | Locked |
A biotechnology company developing autologous immune cell therapies to treat various types of cancer.
|
|
| Locked | Locked | Locked |
Provides in vitro diagnostic services for oncology research and development.
|
Detailed competitors of Oncosyne
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oncosyne
Complete news archive for Oncosyne
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oncosyne
Oncosyne was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Oncosyne is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
Oncosyne specializes in advanced tumoroid platforms for precision medicine in healthcare, focusing on colorectal and pancreatic cancers. They provide tools like iCAN RD and iCAN IVD to accelerate pharmaceutical development and personalize treatments for patients. Collaborating with pharma companies and oncologists, they reduce costs and improve outcomes through innovative drug screening. Based in Sweden, they target global healthcare needs.
Oncosyne's top competitors include Ontogen, AlphaVax and Cancer Research For Oza Rks.
Oncosyne offers iCAN R&D, iCAN IVD, and iCAN Tumoroid Platform.
Oncosyne has 2 investors. Key investors include Fortress Fund, and StartupLab.